-
Early Diet & IBD
The journal Gut recently published the results of a prospective cohort study analyzing the association between diet quality, assessed at age 1 and again at age 3, and the subsequent risk for inflammatory bowel disease (IBD) later in life. Comprised of two Scandinavian cohorts, the All Babies in Southeast Sweden (ABIS) Study and The Norwegian…
-
SBI Cost Savings for IBD Patients
A pilot study has provided evidence of the cost-saving benefits of the incorporation of serum-derived bovine immunoglobulin/protein isolate (SBI) into the therapeutic regimen of people with inflammatory bowel disease (IBD).
-
IBD Management & SBI
A retrospective case series review of people with Crohn’s disease (CD) and ulcerative colitis (UC) whose symptoms weren’t controlled by traditional pharmaceutical therapies showed a symptom improvement rate of 76% after 12 weeks of taking serum-derived bovine immunoglobulin (SBI).